Boston Scientific Corp (NYSE:BSX)
$ 73.69 -0.41 (-0.55%) Market Cap: 108.34 Bil Enterprise Value: 117.61 Bil PE Ratio: 61.92 PB Ratio: 5.44 GF Score: 85/100

Q2 2020 Boston Scientific Corp Earnings Call Transcript

Jul 29, 2020 / 12:00PM GMT
Release Date Price: $39.81 (+4.02%)
Operator

Ladies and gentlemen thank you for standing by. Welcome to the Boston Scientific Second Quarter 2020 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Susan Lisa. Please go ahead.

Susan Vissers Lisa
Boston Scientific Corporation - VP of IR

Thank you, Greg. Good morning, everyone. Thanks for joining us. With me on today's call are Mike Mahoney, Chairman and Chief Executive Officer; and Dan Brennan, Executive Vice President and Chief Financial Officer.

We issued a press release earlier this morning announcing our Q2 2020 results, which include the reconciliations of the non-GAAP measures used in the release. We have posted a copy of that release as well as reconciliations of the non-GAAP measures used in today's call to the Investor Relations section of our website under the heading Financials & Filings.

The duration of this morning's call will be approximately 1 hour.

Mike will focus his comments on Q2

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot